AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Silence Therapeutics plc

Regulatory Filings Apr 29, 2013

33536_rns_2013-04-29_a26a1615-884e-4d69-a6e7-8ed678d53930.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4718D

Silence Therapeutics PLC

29 April 2013

London, 29 April 2013

Silence Therapeutics plc ("Silence Therapeutics" or the "Company")

Result of General Meeting

Silence Therapeutics announces that at its General Meeting held earlier today, the resolutions as set out in the circular send to shareholders on 10 April 2013 in reference to the Placing of New Ordinary Shares and Share Consolidation were duly passed.

Silence Therapeutics

Tim Freeborn, finance director

+44 (0) 333 988 0140

[email protected]

N+1 Singer

Shaun Dobson/Jenny Wyllie

+44 20 7496 3057

[email protected]

[email protected]

This information is provided by RNS

The company news service from the London Stock Exchange

END

REGSEAFFUFDSESL

Talk to a Data Expert

Have a question? We'll get back to you promptly.